Bosh sahifa002294 • SHE
add
Shenzhen Salubris Pharmaceuticals Co Ltd
Yopilish kursi
40,74 ¥
Kunlik diapazon
39,99 ¥ - 41,03 ¥
Yillik diapazon
25,51 ¥ - 41,27 ¥
Bozor kapitalizatsiyasi
45,60 mlrd CNY
Oʻrtacha hajm
9,59 mln
Narx/foyda
76,24
Dividend daromadliligi
-
Asosiy maydon
SHE
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (CNY) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 1,06 mlrd | -2,64% |
Joriy xarajat | 591,80 mln | 6,55% |
Sof foyda | 200,33 mln | 0,03% |
Sof foyda marjasi | 18,86 | 2,72% |
Har bir ulushga tushum | — | — |
EBITDA | 298,43 mln | -2,46% |
Amaldagi soliq stavkasi | 11,01% | — |
Balans
Jami aktivlari
Jami passivlari
| (CNY) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 2,71 mlrd | 53,81% |
Jami aktivlari | 10,66 mlrd | 10,96% |
Jami passivlari | 1,70 mlrd | 26,43% |
Umumiy kapital | 8,96 mlrd | — |
Tarqatilgan aksiyalar | 1,11 mlrd | — |
Narxi/balansdagi bahosi | 5,09 | — |
Aktivlardan daromad | 4,93% | — |
Kapitaldan daromad | 5,79% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (CNY) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 200,33 mln | 0,03% |
Operatsiyalardan naqd pul | 169,39 mln | -26,39% |
Sarmoyadan naqd pul | 127,46 mln | 219,62% |
Moliyadan naqd pul | 16,61 mln | 149,11% |
Naqd pulning sof oʻzgarishi | 311,38 mln | 244,57% |
Boʻsh pul | -850,75 mln | -46,03% |
Haqida
Shenzhen Salubris Pharmaceuticals is a Chinese pharmaceutical company.
Founded in November 1998 and based in Shenzhen, it has a market cap of US$4.4 billion, 3,121 employees and annual sales of $553 million as of 2019.
Shenzhen Salubris is headed by the billionaire Ye Chenghai. Wikipedia
Tashkil etilgan
3-noy, 1998
Sayt
Xodimlar soni
3 596
